Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ruzzetti

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|August 18, 2009
Is there an association between topiramate and granuloma annulare?M Ruzzetti, R Saraceno, K Peris, et al.
Dermatology (Basel, Switzerland)|November 28, 2012
Prevalence and management of panic attacks during infliximab infusion in psoriatic patientsR Saraceno, S Faleri, M Ruzzetti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 10, 2008
Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximabM Ruzzetti, R Saraceno, I Carboni, et al.
Dermatology (Basel, Switzerland)|August 25, 2010
The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximabM Papoutsaki, M Talamonti, A Giunta, et al.
European Review for Medical and Pharmacological Sciences|November 26, 2008
Does metabolic syndrome influence psoriasis?R Saraceno, M Ruzzetti, M U De Martino, et al.
Mediators of Inflammation|August 20, 2014
Immunologic biomarkers for clinical and therapeutic management of psoriasisP Cordiali-Fei, L Bianchi, C Bonifati, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of the European Academy of Dermatology and Venereology : JEADV|August 18, 2009
Is there an association between topiramate and granuloma annulare?M Ruzzetti, R Saraceno, K Peris, et al.
Dermatology (Basel, Switzerland)|November 28, 2012
Prevalence and management of panic attacks during infliximab infusion in psoriatic patientsR Saraceno, S Faleri, M Ruzzetti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 10, 2008
Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximabM Ruzzetti, R Saraceno, I Carboni, et al.
Dermatology (Basel, Switzerland)|August 25, 2010
The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximabM Papoutsaki, M Talamonti, A Giunta, et al.
European Review for Medical and Pharmacological Sciences|November 26, 2008
Does metabolic syndrome influence psoriasis?R Saraceno, M Ruzzetti, M U De Martino, et al.
Mediators of Inflammation|August 20, 2014
Immunologic biomarkers for clinical and therapeutic management of psoriasisP Cordiali-Fei, L Bianchi, C Bonifati, et al.
Pageof 1